Failure of stavudine‐lamivudine combination therapy in antiretroviral‐naive patients with AZT‐Like HIV‐1 resistance mutations
Loredana Sarmati(University of Rome Tor Vergata), Massimo Andreoni(University of Rome Tor Vergata), Cino Traina(University of Rome Tor Vergata), Nogare Ernesto Renato Dalle, Vincenzo Abbadessa(University of Rome Tor Vergata), Emanuele Nicastri(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Vincenzo Vullo(Sapienza University of Rome), Giorgio Mancino(University of Rome Tor Vergata), Pasquale Narciso(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Saverio Giuseppe Parisi(University of Verona), Gabriella d’Ettorre(Policlinico Umberto I)
Cited by 14
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2001|470
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272